HIV infection is associated with an increased risk for lung cancer, independent of smoking

被引:273
作者
Kirk, Gregory D.
Merlo, Christian
O' Driscoll, Peter
Mehta, Shruti H.
Galai, Noya
Vlahov, David
Samet, Jonathan
Engels, Eric A.
机构
[1] Johns Hopkins Univ, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] NCI, Viral Epidemiol Branch, NIH, Rockville, MD USA
[4] New York Acad Med, New York, NY USA
关键词
D O I
10.1086/518606
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human immunodeficiency virus ( HIV)-infected persons have an elevated risk for lung cancer, but whether the increase reflects solely their heavy tobacco use remains an open question. Methods. The Acquired Immunodeficiency Syndrome ( AIDS) Link to the Intravenous Experience Study has prospectively observed a cohort of injection drug users in Baltimore, Maryland, since 1988, using biannual collection of clinical, laboratory, and behavioral data. Lung cancer deaths were identified through linkage with the National Death Index. Cox proportional hazards regression was used to examine the effect of HIV infection on lung cancer risk, controlling for smoking status, drug use, and clinical variables. Results. Among 2086 AIDS Link to the Intravenous Experience Study participants observed for 19,835 person-years, 27 lung cancer deaths were identified; 14 of the deaths were among HIV-infected persons. All but 1 ( 96%) of the patients with lung cancer were smokers, smoking a mean of 1.2 packs per day. Lung cancer mortality increased during the highly active antiretroviral therapy era, compared with the pre-highly active antiretroviral therapy period ( mortality rate ratio, 4.7; 95% confidence interval, 1.7-16). After adjusting for age, sex, smoking status, and calendar period, HIV infection was associated with increased lung cancer risk ( hazard ratio, 3.6; 95% confidence interval, 1.6-7.9). Preexisting lung disease, particularly noninfectious diseases and asthma, displayed trends for increased lung cancer risk. Illicit drug use was not associated with increased lung cancer risk. Among HIV-infected persons, smoking remained the major risk factor; CD4 cell count and HIV load were not strongly associated with increased lung cancer risk, and trends for increased risk with use of highly active antiretroviral therapy were not significant. Conclusions. HIV infection is associated with significantly increased risk for developing lung cancer, independent of smoking status.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 42 条
[1]   PREEXISTING LUNG-DISEASE AND LUNG-CANCER AMONG NONSMOKING WOMEN [J].
ALAVANJA, MCR ;
BROWNSON, RC ;
BOICE, JD ;
HOCK, E .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (06) :623-632
[2]   Incidence of malignant neoplasms among HIV-infected persons in Scotland [J].
Allardice, GM ;
Hole, DJ ;
Brewster, DH ;
Boyd, J ;
Goldberg, DJ .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :505-507
[3]  
Bénard A, 2006, INT J TUBERC LUNG D, V10, P378
[4]   Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy [J].
Bonnet, F ;
Lewden, C ;
May, T ;
Heripret, L ;
Jougla, E ;
Bevilacqua, S ;
Costagliola, D ;
Salmon, D ;
Chêne, G ;
Morlat, P .
CANCER, 2004, 101 (02) :317-324
[5]   HIV-related lung cancer in the era of highly active antiretroviral therapy [J].
Bower, M ;
Powles, T ;
Nelson, M ;
Shah, P ;
Cox, S ;
Mandelia, S ;
Gazzard, B .
AIDS, 2003, 17 (03) :371-375
[6]   Previous lung disease and lung cancer risk among women (United States) [J].
Brownson, RC ;
Alavanja, MCR .
CANCER CAUSES & CONTROL, 2000, 11 (09) :853-858
[7]   DRUG SMOKING, PNEUMOCYSTIS-CARINII PNEUMONIA, AND IMMUNOSUPPRESSION INCREASE RISK OF BACTERIAL PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INJECTION-DRUG USERS [J].
CAIAFFA, WT ;
VLAHOV, D ;
GRAHAM, NMH ;
ASTEMBORSKI, J ;
SOLOMON, L ;
NELSON, KE ;
MUNOZ, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1493-1498
[8]   Elevated risk of lung cancer among people with AIDS [J].
Chaturvedi, Anil K. ;
Pfeiffer, Ruth M. ;
Chang, Leonard ;
Goedert, James J. ;
Biggar, Robert J. ;
Engels, Eric A. .
AIDS, 2007, 21 (02) :207-213
[9]   Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].
Clifford, GM ;
Polesel, J ;
Rickenbach, M ;
Dal Maso, L ;
Keiser, O ;
Kofler, A ;
Rapiti, E ;
Levi, F ;
Jundt, G ;
Fisch, T ;
Bordoni, A ;
De Weck, D ;
Franceschi, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432
[10]   Lung cancer in persons with AIDS in Italy, 1985-1998 [J].
Dal Maso, L ;
Polesel, J ;
Serraino, D ;
Franceschi, S .
AIDS, 2003, 17 (14) :2117-2119